Back to search

Article

Reduced myofibroblast transdifferentiation and fibrotic scarring in ischemic stroke after imatinib treatment

2021-10-28

Abstract excerpt

The tyrosine kinase inhibitor imatinib has been reported to improve outcome in patients following ischemic stroke but the exact mechanism remains elusive. Here, utilizing a photothrombotic murine model of middle cerebral artery occlusion (MCAO), we show that imatinib-mediated inhibition of stroke-induced blood-brain barrier (BBB) dysfunction coincided with decreased expression of genes associated with inflammation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
faaccbba-5b70-501c-9e69-c286d7a4d828
DOI
10.1101/2021.10.28.466225
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Reduced myofibroblast transdifferentiation and fibrotic scarring in ischemic stroke after imatinib treatmentDOI 10.1101/2021.10.28.466225
Select a neighboring publication to make it the new centre.